| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.44 | 0.02 |